Episodic Heavy Drinking Triples Liver Damage Risk
Analysis based on 11 articles · First reported Apr 02, 2026 · Last updated Apr 07, 2026
The study's findings could influence public health campaigns and potentially impact the alcoholic beverage industry as consumers become more aware of the risks of episodic heavy drinking. It may also spur further research and development in liver disease treatments and diagnostics within the healthcare sector.
New research from Keck Medicine of USC, led by Brian P. Lee, published in Clinical Gastroenterology and Hepatology, reveals that episodic heavy drinking significantly increases the risk of advanced liver fibrosis, particularly for individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). The study, which analyzed data from over 8,000 adults from the United States===National Health and Nutrition Examination Survey, found that those who consume large amounts of alcohol in a single day at least once a month are three times more likely to develop severe liver scarring than those who spread out their alcohol intake. This challenges the common belief that moderate drinking during the week mitigates the harm of occasional heavy drinking. The United States===National Institute on Alcohol Abuse and Alcoholism supported this research, which emphasizes the importance of drinking patterns over total consumption in assessing liver health risks.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard